acetylcysteine has been researched along with Colitis Gravis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Masnadi Shirazi, A; Masnadi Shirazi, K; Moaddab, SY; Nikniaz, Z; Nourpanah, Z; Sotoudeh, S | 1 |
| Chen, X; Ding, B; Hou, Y; Liu, Y; Long, M; Wang, L; Wang, Q; Wu, G; Yi, D | 1 |
| Aytekin, H; Tahan, G; Tahan, V; Uraz, S | 1 |
| Bulbuloglu, E; Cetinkaya, A; Kantarceken, B; Kurutas, EB | 1 |
| Bardini, KC; Benetton, CA; Cardoso, VH; Dal-Pizzol, F; Damiani, CR; Di Giunta, G; Pinho, RA; Stoffel, C; Streck, EL | 1 |
| Arriaza, E; Castillejo, MS; Delgado, M; Gisbert, JP; Gonzalez Lara, V; Guijarro, LG; Marin-Jimenez, I; Mate, J; Olleros, T; Pena, AS; Perez-Calle, JL; Prieto-Merino, D | 1 |
| Ho, KL; Liao, J; Seril, DN; Yang, CS; Yang, GY | 1 |
2 trial(s) available for acetylcysteine and Colitis Gravis
| Article | Year |
|---|---|
Effect of N-acetylcysteine on remission maintenance in patients with ulcerative colitis: A randomized, double-blind controlled clinical trial.
Topics: Acetylcysteine; C-Reactive Protein; Colitis, Ulcerative; Humans; Leukocyte L1 Antigen Complex; Neoplasm Recurrence, Local | 2021 |
N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study.
Topics: Acetylcysteine; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Chemokine CCL2; Colitis, Ulcerative; Drug Therapy, Combination; Female; Free Radical Scavengers; Glutathione; Humans; Interleukin-6; Interleukin-8; Male; Mesalamine; Middle Aged; Pilot Projects; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2008 |
5 other study(ies) available for acetylcysteine and Colitis Gravis
| Article | Year |
|---|---|
Protective effects of N-acetylcysteine on acetic acid-induced colitis in a porcine model.
Topics: Acetic Acid; Acetylcysteine; Amphiregulin; Animals; Apoptosis; Caspase 3; Claudin-1; Colitis; Colitis, Ulcerative; Colon; Dietary Supplements; Dinoprostone; Disease Models, Animal; EGF Family of Proteins; Epidermal Growth Factor; ErbB Receptors; Free Radical Scavengers; Glycoproteins; Intercellular Signaling Peptides and Proteins; Interleukin-6; Intestinal Mucosa; Swine; Toll-Like Receptor 4; Transforming Growth Factor alpha; Tumor Necrosis Factor-alpha | 2013 |
N-acetylcysteine expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic acid-induced colitis in rats.
Topics: Acetic Acid; Acetylcysteine; Animals; Anti-Inflammatory Agents; Antioxidants; Colitis, Ulcerative; Colon; Cytokines; Female; Male; Malondialdehyde; Organ Size; Peroxidase; Rats; Rats, Wistar | 2013 |
Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-superoxide dismutase and plasma malondialdehyde levels in experimental colitis.
Topics: Acetylcysteine; Animals; Antioxidants; Carnitine; Colitis, Ulcerative; Free Radical Scavengers; Leukocytes; Male; Malondialdehyde; Peroxidase; Rats; Rats, Wistar; Superoxide Dismutase; Vitamin B Complex | 2005 |
Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antioxidants; Colitis, Ulcerative; Colon; Deferoxamine; Dextran Sulfate; Disease Models, Animal; Electron Transport Complex II; Electron Transport Complex IV; Gastrointestinal Agents; Leukocyte Count; Lipid Peroxidation; Male; Mitochondria; Oxidative Stress; Rats; Rats, Wistar; Succinate Dehydrogenase; Thiobarbituric Acid Reactive Substances | 2007 |
Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine.
Topics: Acetylcysteine; Adenocarcinoma; Animals; Anticarcinogenic Agents; Antioxidants; Cell Division; Colitis, Ulcerative; Colorectal Neoplasms; Disease Models, Animal; Female; Mice; Mice, Inbred C57BL | 2002 |